Guangdong Maijinjia Biotechnologies Co., Ltd. is a privately held company and is a one-of-a- kind joint venture between Danish and Chinese founders. Together our founders bring a total of more than 50 years of experience with small RNAs, modified oligonucleotides, patenting, clinical trials, biotechnology and business in general to the table. Our investors are:
Series-A+ Investment
Guangzhou Science City Venture Capital Management Co., Ltd. & Zhichuang No. 1 (Guangzhou) Industrial Investment Fund Partnership (Limited Partnership)
Series-A investment (January, 2020)
Guangzhou Science City Venture Capital Management Co., Ltd.
Founed in 2018, Guangzhou Science City venture Capital Co,.Ltd got certificated to license of fund management company in Nov, 2019（code: P1070403）and manage around 800 million yuan.It mainly centers on funds and direct government fund investment by pay close attention to startups of IAB and major consumption industries. It has built a seasoned professional investment decision-making team who has bank and fund backgrounds as well as rich industrial and financial resources. It has established mature chained management systems for project evaluation and selection,project risk control risk control, project incubation and personalized value-added services.
Angel Investment（August, 2019）
Guangzhou Aoqi Shengjia Technology Partnership (Limited Partnership)
Guangzhou Aoqi Shengjia Technology Partnership (Limited Partnership) was established on December 10, 2018. Its business scope focuses on medical technology transfer services;Medical technical consultation and exchange services;Medical technology extension services. Currently, the company has invested one company.
